title: Everolimus with low-dose cyclosporine in de novo renal transplant recipients: A single center Indian experience.
authors.affiliation: Transimmun-Transplantation Immunology and Research Center, Somajiguda, Hyderabad, India.
authors.forename: Sailaja
authors.initials: S
authors.lastname: Kesiraju
authors.forename: Uma Maheswara
authors.initials: UM
authors.lastname: Rao
authors.forename: Purna
authors.initials: P
authors.lastname: Paritala
authors.forename: V S
authors.initials: VS
authors.lastname: Reddy
authors.forename: S
authors.initials: S
authors.lastname: Sahariah
mesh_terms: D000328:Adult; D065095:Calcineurin Inhibitors / Q000627:therapeutic use; D003404:Creatinine / Q000493:pharmacokinetics; D016572:Cyclosporine / Q000008:administration & dosage* / Q000493:pharmacokinetics; D004359:Drug Therapy, Combination; D000068338:Everolimus / Q000008:administration & dosage* / Q000493:pharmacokinetics; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage*; D007194:India; D016030:Kidney Transplantation / Q000009:adverse effects; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D066027:Transplant Recipients; D016896:Treatment Outcome; D055815:Young Adult
chemical_list: D065095:Calcineurin Inhibitors; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D000068338:Everolimus; D003404:Creatinine